Cliniphar Co., Ltd. logo

Cliniphar Co., Ltd. (432A)

Market Closed
12 Aug, 06:00
JPX JPX
¥
1,450. 00
0
0%
¥
1.45B Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
¥ 1,450
Previous Close
Add Transaction
Day Range
1,450 1,450
Year Range
1,450 1,450
Want to track 432A and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

432A closed yesterday higher at ¥1,450, an increase of 0% from Tuesday's close, completing a monthly increase of 0% or ¥0. Over the past 12 months, 432A stock gained 0%.
432A is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

432A Chart

Cliniphar Co., Ltd. (432A) FAQ

What is the stock price today?

The current price is ¥1,450.00.

On which exchange is it traded?

Cliniphar Co., Ltd. is listed on JPX.

What is its stock symbol?

The ticker symbol is 432A.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.45B.

Has Cliniphar Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Cliniphar Co., Ltd. Profile

- Industry
- Sector
Kohei Toda CEO
JPX Exchange
- ISIN
Japan Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Cliniphar Co., Ltd. is a prominent holding company established in 2017, specializing in the wholesale and distribution of pharmaceuticals in both the domestic Japanese market and international arenas. With its headquarters located in Osaka, Cliniphar is instrumental in enhancing healthcare logistics by effectively integrating its subsidiaries and harnessing synergies within the healthcare industry. The company is dedicated to delivering efficiency and innovation in pharmaceutical distribution, showcasing its significant role in advancing supply chain processes.

Cliniphar manages an expansive portfolio of over 17,000 prescription products, collaborating closely with approximately 12,000 healthcare professionals and institutions. Its strong market presence emphasizes its critical function as an intermediary in the healthcare ecosystem, facilitating supply chain innovation and reliability to ensure hospitals, clinics, and pharmacies have reliable access to a comprehensive range of pharmaceuticals.

Products and Services

  • Wholesale and Distribution of Pharmaceuticals:

    Cliniphar specializes in the wholesale distribution of a wide array of pharmaceutical products, serving as a vital link between manufacturers and healthcare providers. By managing an extensive portfolio, the company ensures that healthcare institutions have access to essential medications and treatments.

  • B2B E-commerce Platforms:

    Cliniphar operates advanced B2B e-commerce platforms tailored for healthcare providers, including Kosei Market. These platforms enhance the accessibility and ordering process of pharmaceutical products, streamlining communications between distributors and healthcare professionals.

  • Digital Drug Databases:

    Through resources like Synapse, Cliniphar maintains comprehensive digital drug databases that serve both the Japanese and global medical sectors. These databases assist healthcare providers in obtaining crucial information regarding pharmaceutical products, dosage guidelines, and availability.

  • Healthcare Logistics Solutions:

    Cliniphar is committed to innovating healthcare logistics. By integrating its subsidiaries and optimizing supply chain processes, the company plays a pivotal role in ensuring a stable supply of pharmaceutical products to various healthcare facilities.

Contact Information

Address: OMM Building
Phone: 81 6 6941 9288